Inhibition of toll-like receptor 4 alleviates hyperalgesia induced by acute dural inflammation in experimental migraine

Min Su, Ye Ran, Zizi He, Mingjie Zhang, Guanqun Hu, Wenjing Tang, Dengfa Zhao, Shengyuan Yu, Min Su, Ye Ran, Zizi He, Mingjie Zhang, Guanqun Hu, Wenjing Tang, Dengfa Zhao, Shengyuan Yu

Abstract

Objective Although nociceptive sensitisation is an important pathophysiological process in migraine and migraine chronification, its underlying mechanisms remain unclear. Toll-like receptor 4 (TLR4), a pattern-recognition molecule, has a critical role in both neuropathic pain and morphine tolerance. The present study examined whether elements of the TLR4 pathway contribute to hyperalgesia induced by dural inflammation in rats. Methods A rat model of migraine was established by infusing a dural inflammatory soup. A group pretreated with TAK-242 was used to inhibit the activation of TLR4. The protein levels of TLR4 and its downstream molecules in the trigeminal pathway were examined by Western blot and immunofluorescence. The expression of activated microglia and astrocytes was also analysed. Levels of interleukin-1 beta, tumour necrosis factor-alpha, and brain-derived neurotrophic factor were measured by enzyme-linked immunosorbent assay. Results Acute inflammatory soup infusion induced time-dependent facial mechanical hyperalgesia, which was blocked by TAK-242 pretreatment. The inflammatory soup stimulus increased the production of TLR4 downstream molecules and interleukin-1 beta. Higher levels of microglia activation and brain-derived neurotrophic factor release were observed following the administration of the inflammatory soup but were alleviated by TAK-242. Conclusions These data suggest that the TLR4 signalling pathway promotes hyperalgesia induced by acute inflammatory soup delivery by stimulating the production of proinflammatory cytokines and activating microglia.

Keywords: Migraine; hyperalgesia; microglia; neuroinflammation; toll-like receptor 4.

Figures

Figure 1.
Figure 1.
The mechanical (a) or thermal (b) withdrawal thresholds of rats during the 6-hour experiment. Data are presented as the mean ± SD, n = 9. Compared with the CON group, rats in IS group showed a time-dependent and reversible decline in periorbital withdrawal thresholds to mechanical stimulus (*P 

Figure 2.

The level of Fos in…

Figure 2.

The level of Fos in trigeminal ganglion (a), trigeminal nucleus caudalis (b), and…

Figure 2.
The level of Fos in trigeminal ganglion (a), trigeminal nucleus caudalis (b), and upper cervical spinal cord (c). All values given are the mean ± SD, n = 4. *P 

Figure 3.

The protein levels of TLR4…

Figure 3.

The protein levels of TLR4 and its downstream molecules in rats’ medullary and…

Figure 3.
The protein levels of TLR4 and its downstream molecules in rats’ medullary and upper cervical spinal cord. Protein levels of TLR4 (a), MyD88 (b), and TRIF (c) were analysed by Western blot. Typical Western blot strips obtained were exhibited at the top of each image, and for all strips, each blot from left to right means sample from rat in group CON, IS, and TAK-242, respectively. All values given are the mean ± SD, n = 5. *P 

Figure 4.

The protein levels of NF-κB…

Figure 4.

The protein levels of NF-κB p65 and related molecules in rats’ medullary and…

Figure 4.
The protein levels of NF-κB p65 and related molecules in rats’ medullary and upper cervical spinal cord. Protein levels of IκB (a), p-IκB (b), NF-κB p65 (c), and nuclear NF-κB p65 (d) were analysed by Western blot. Typical Western blot strips obtained were exhibited at the top of each image, and for all strips, each blot from left to right means sample from rat in group CON, IS, and TAK-242, respectively. All values given are the mean ± SD, n = 5. #P 

Figure 5.

Immunofluorescence of TLR4 and NF-κB…

Figure 5.

Immunofluorescence of TLR4 and NF-κB p65 expression in the trigeminal pathway. The typical…

Figure 5.
Immunofluorescence of TLR4 and NF-κB p65 expression in the trigeminal pathway. The typical immunofluorescence samples were presented at the left part of the image, with the scale bar equalling to 50 μm. The right part showed the statistical results of NF-κB p65 expression in TG (a), TNC (b), and UCSC (c), respectively. All values given are the mean ± SD, n = 4. #P 

Figure 6.

The protein levels of IL-1β…

Figure 6.

The protein levels of IL-1β (a), TNF-α (b), and BDNF (c) in rat…

Figure 6.
The protein levels of IL-1β (a), TNF-α (b), and BDNF (c) in rat brain by enzyme-linked immunosorbent assay. All values given are the mean ± SD, n = 5. #P 

Figure 7.

Expression of microglia (a) and…

Figure 7.

Expression of microglia (a) and astrocytes (b) activating marker in rats’ medullary and…

Figure 7.
Expression of microglia (a) and astrocytes (b) activating marker in rats’ medullary and upper cervical spinal cord. Protein levels of Iba-1 (ionised calcium-binding adapter molecule 1) and GFAP (glia fibrillary acidic protein) were analysed by Western blot. Typical Western blot strips obtained were exhibited at the top of each image, and for all strips, each blot from left to right means sample from rat in group CON, IS, and TAK-242, respectively. All values given are the mean ± SD, n = 5. #P 

Figure 8.

Immunofluorescence of Iba-1 and GFAP…

Figure 8.

Immunofluorescence of Iba-1 and GFAP expression in the trigeminal pathway. The typical immunofluorescence…

Figure 8.
Immunofluorescence of Iba-1 and GFAP expression in the trigeminal pathway. The typical immunofluorescence samples were presented at the left part of the image, with the scale bar equalling to 50 μm. The right part showed the statistical results of Iba-1 expression in TNC (a) and UCSC (b), respectively. All values given are the mean ± SD, n = 4. #P 
All figures (8)
Similar articles
Cited by
References
    1. Steiner TJ Stovner LJ andVos T.. GBD 2015: migraine is the third cause of disability in under 50s. J Headache Pain 2016; 17: 104. - PMC - PubMed
    1. Goadsby PJ, Holland PR, Martinsoliveira M, et al. Pathophysiology of migraine: a disorder of sensory processing. Physiol Rev 2017; 97: 553. - PMC - PubMed
    1. Mathew NT Kailasam J andSeifert T.. Clinical recognition of allodynia in migraine. Neurology 2004; 63: 848–852. - PubMed
    1. Noseda R and Burstein R.. Migraine pathophysiology: anatomy of the trigeminovascular pathway and associated neurological symptoms, CSD, sensitization and modulation of pain. Pain 2013; 154 Suppl 1 (6): S44-S53 - PubMed
    1. Moskowitz MA. Neurogenic inflammation in the pathophysiology and treatment of migraine. Neurology 1993; 43: 16–20. - PubMed
Show all 31 references
Publication types
MeSH terms
Substances
Full text links [x]
[x]
Cite
Copy Download .nbib
Format: AMA APA MLA NLM

NCBI Literature Resources

MeSH PMC Bookshelf Disclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.

Follow NCBI
Figure 2.
Figure 2.
The level of Fos in trigeminal ganglion (a), trigeminal nucleus caudalis (b), and upper cervical spinal cord (c). All values given are the mean ± SD, n = 4. *P 

Figure 3.

The protein levels of TLR4…

Figure 3.

The protein levels of TLR4 and its downstream molecules in rats’ medullary and…

Figure 3.
The protein levels of TLR4 and its downstream molecules in rats’ medullary and upper cervical spinal cord. Protein levels of TLR4 (a), MyD88 (b), and TRIF (c) were analysed by Western blot. Typical Western blot strips obtained were exhibited at the top of each image, and for all strips, each blot from left to right means sample from rat in group CON, IS, and TAK-242, respectively. All values given are the mean ± SD, n = 5. *P 

Figure 4.

The protein levels of NF-κB…

Figure 4.

The protein levels of NF-κB p65 and related molecules in rats’ medullary and…

Figure 4.
The protein levels of NF-κB p65 and related molecules in rats’ medullary and upper cervical spinal cord. Protein levels of IκB (a), p-IκB (b), NF-κB p65 (c), and nuclear NF-κB p65 (d) were analysed by Western blot. Typical Western blot strips obtained were exhibited at the top of each image, and for all strips, each blot from left to right means sample from rat in group CON, IS, and TAK-242, respectively. All values given are the mean ± SD, n = 5. #P 

Figure 5.

Immunofluorescence of TLR4 and NF-κB…

Figure 5.

Immunofluorescence of TLR4 and NF-κB p65 expression in the trigeminal pathway. The typical…

Figure 5.
Immunofluorescence of TLR4 and NF-κB p65 expression in the trigeminal pathway. The typical immunofluorescence samples were presented at the left part of the image, with the scale bar equalling to 50 μm. The right part showed the statistical results of NF-κB p65 expression in TG (a), TNC (b), and UCSC (c), respectively. All values given are the mean ± SD, n = 4. #P 

Figure 6.

The protein levels of IL-1β…

Figure 6.

The protein levels of IL-1β (a), TNF-α (b), and BDNF (c) in rat…

Figure 6.
The protein levels of IL-1β (a), TNF-α (b), and BDNF (c) in rat brain by enzyme-linked immunosorbent assay. All values given are the mean ± SD, n = 5. #P 

Figure 7.

Expression of microglia (a) and…

Figure 7.

Expression of microglia (a) and astrocytes (b) activating marker in rats’ medullary and…

Figure 7.
Expression of microglia (a) and astrocytes (b) activating marker in rats’ medullary and upper cervical spinal cord. Protein levels of Iba-1 (ionised calcium-binding adapter molecule 1) and GFAP (glia fibrillary acidic protein) were analysed by Western blot. Typical Western blot strips obtained were exhibited at the top of each image, and for all strips, each blot from left to right means sample from rat in group CON, IS, and TAK-242, respectively. All values given are the mean ± SD, n = 5. #P 

Figure 8.

Immunofluorescence of Iba-1 and GFAP…

Figure 8.

Immunofluorescence of Iba-1 and GFAP expression in the trigeminal pathway. The typical immunofluorescence…

Figure 8.
Immunofluorescence of Iba-1 and GFAP expression in the trigeminal pathway. The typical immunofluorescence samples were presented at the left part of the image, with the scale bar equalling to 50 μm. The right part showed the statistical results of Iba-1 expression in TNC (a) and UCSC (b), respectively. All values given are the mean ± SD, n = 4. #P 
All figures (8)
Similar articles
Cited by
References
    1. Steiner TJ Stovner LJ andVos T.. GBD 2015: migraine is the third cause of disability in under 50s. J Headache Pain 2016; 17: 104. - PMC - PubMed
    1. Goadsby PJ, Holland PR, Martinsoliveira M, et al. Pathophysiology of migraine: a disorder of sensory processing. Physiol Rev 2017; 97: 553. - PMC - PubMed
    1. Mathew NT Kailasam J andSeifert T.. Clinical recognition of allodynia in migraine. Neurology 2004; 63: 848–852. - PubMed
    1. Noseda R and Burstein R.. Migraine pathophysiology: anatomy of the trigeminovascular pathway and associated neurological symptoms, CSD, sensitization and modulation of pain. Pain 2013; 154 Suppl 1 (6): S44-S53 - PubMed
    1. Moskowitz MA. Neurogenic inflammation in the pathophysiology and treatment of migraine. Neurology 1993; 43: 16–20. - PubMed
Show all 31 references
Publication types
MeSH terms
Substances
Full text links [x]
[x]
Cite
Copy Download .nbib
Format: AMA APA MLA NLM

NCBI Literature Resources

MeSH PMC Bookshelf Disclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.

Follow NCBI
Figure 3.
Figure 3.
The protein levels of TLR4 and its downstream molecules in rats’ medullary and upper cervical spinal cord. Protein levels of TLR4 (a), MyD88 (b), and TRIF (c) were analysed by Western blot. Typical Western blot strips obtained were exhibited at the top of each image, and for all strips, each blot from left to right means sample from rat in group CON, IS, and TAK-242, respectively. All values given are the mean ± SD, n = 5. *P 

Figure 4.

The protein levels of NF-κB…

Figure 4.

The protein levels of NF-κB p65 and related molecules in rats’ medullary and…

Figure 4.
The protein levels of NF-κB p65 and related molecules in rats’ medullary and upper cervical spinal cord. Protein levels of IκB (a), p-IκB (b), NF-κB p65 (c), and nuclear NF-κB p65 (d) were analysed by Western blot. Typical Western blot strips obtained were exhibited at the top of each image, and for all strips, each blot from left to right means sample from rat in group CON, IS, and TAK-242, respectively. All values given are the mean ± SD, n = 5. #P 

Figure 5.

Immunofluorescence of TLR4 and NF-κB…

Figure 5.

Immunofluorescence of TLR4 and NF-κB p65 expression in the trigeminal pathway. The typical…

Figure 5.
Immunofluorescence of TLR4 and NF-κB p65 expression in the trigeminal pathway. The typical immunofluorescence samples were presented at the left part of the image, with the scale bar equalling to 50 μm. The right part showed the statistical results of NF-κB p65 expression in TG (a), TNC (b), and UCSC (c), respectively. All values given are the mean ± SD, n = 4. #P 

Figure 6.

The protein levels of IL-1β…

Figure 6.

The protein levels of IL-1β (a), TNF-α (b), and BDNF (c) in rat…

Figure 6.
The protein levels of IL-1β (a), TNF-α (b), and BDNF (c) in rat brain by enzyme-linked immunosorbent assay. All values given are the mean ± SD, n = 5. #P 

Figure 7.

Expression of microglia (a) and…

Figure 7.

Expression of microglia (a) and astrocytes (b) activating marker in rats’ medullary and…

Figure 7.
Expression of microglia (a) and astrocytes (b) activating marker in rats’ medullary and upper cervical spinal cord. Protein levels of Iba-1 (ionised calcium-binding adapter molecule 1) and GFAP (glia fibrillary acidic protein) were analysed by Western blot. Typical Western blot strips obtained were exhibited at the top of each image, and for all strips, each blot from left to right means sample from rat in group CON, IS, and TAK-242, respectively. All values given are the mean ± SD, n = 5. #P 

Figure 8.

Immunofluorescence of Iba-1 and GFAP…

Figure 8.

Immunofluorescence of Iba-1 and GFAP expression in the trigeminal pathway. The typical immunofluorescence…

Figure 8.
Immunofluorescence of Iba-1 and GFAP expression in the trigeminal pathway. The typical immunofluorescence samples were presented at the left part of the image, with the scale bar equalling to 50 μm. The right part showed the statistical results of Iba-1 expression in TNC (a) and UCSC (b), respectively. All values given are the mean ± SD, n = 4. #P 
All figures (8)
Similar articles
Cited by
References
    1. Steiner TJ Stovner LJ andVos T.. GBD 2015: migraine is the third cause of disability in under 50s. J Headache Pain 2016; 17: 104. - PMC - PubMed
    1. Goadsby PJ, Holland PR, Martinsoliveira M, et al. Pathophysiology of migraine: a disorder of sensory processing. Physiol Rev 2017; 97: 553. - PMC - PubMed
    1. Mathew NT Kailasam J andSeifert T.. Clinical recognition of allodynia in migraine. Neurology 2004; 63: 848–852. - PubMed
    1. Noseda R and Burstein R.. Migraine pathophysiology: anatomy of the trigeminovascular pathway and associated neurological symptoms, CSD, sensitization and modulation of pain. Pain 2013; 154 Suppl 1 (6): S44-S53 - PubMed
    1. Moskowitz MA. Neurogenic inflammation in the pathophysiology and treatment of migraine. Neurology 1993; 43: 16–20. - PubMed
Show all 31 references
Publication types
MeSH terms
Substances
Full text links [x]
[x]
Cite
Copy Download .nbib
Format: AMA APA MLA NLM

NCBI Literature Resources

MeSH PMC Bookshelf Disclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.

Follow NCBI
Figure 4.
Figure 4.
The protein levels of NF-κB p65 and related molecules in rats’ medullary and upper cervical spinal cord. Protein levels of IκB (a), p-IκB (b), NF-κB p65 (c), and nuclear NF-κB p65 (d) were analysed by Western blot. Typical Western blot strips obtained were exhibited at the top of each image, and for all strips, each blot from left to right means sample from rat in group CON, IS, and TAK-242, respectively. All values given are the mean ± SD, n = 5. #P 

Figure 5.

Immunofluorescence of TLR4 and NF-κB…

Figure 5.

Immunofluorescence of TLR4 and NF-κB p65 expression in the trigeminal pathway. The typical…

Figure 5.
Immunofluorescence of TLR4 and NF-κB p65 expression in the trigeminal pathway. The typical immunofluorescence samples were presented at the left part of the image, with the scale bar equalling to 50 μm. The right part showed the statistical results of NF-κB p65 expression in TG (a), TNC (b), and UCSC (c), respectively. All values given are the mean ± SD, n = 4. #P 

Figure 6.

The protein levels of IL-1β…

Figure 6.

The protein levels of IL-1β (a), TNF-α (b), and BDNF (c) in rat…

Figure 6.
The protein levels of IL-1β (a), TNF-α (b), and BDNF (c) in rat brain by enzyme-linked immunosorbent assay. All values given are the mean ± SD, n = 5. #P 

Figure 7.

Expression of microglia (a) and…

Figure 7.

Expression of microglia (a) and astrocytes (b) activating marker in rats’ medullary and…

Figure 7.
Expression of microglia (a) and astrocytes (b) activating marker in rats’ medullary and upper cervical spinal cord. Protein levels of Iba-1 (ionised calcium-binding adapter molecule 1) and GFAP (glia fibrillary acidic protein) were analysed by Western blot. Typical Western blot strips obtained were exhibited at the top of each image, and for all strips, each blot from left to right means sample from rat in group CON, IS, and TAK-242, respectively. All values given are the mean ± SD, n = 5. #P 

Figure 8.

Immunofluorescence of Iba-1 and GFAP…

Figure 8.

Immunofluorescence of Iba-1 and GFAP expression in the trigeminal pathway. The typical immunofluorescence…

Figure 8.
Immunofluorescence of Iba-1 and GFAP expression in the trigeminal pathway. The typical immunofluorescence samples were presented at the left part of the image, with the scale bar equalling to 50 μm. The right part showed the statistical results of Iba-1 expression in TNC (a) and UCSC (b), respectively. All values given are the mean ± SD, n = 4. #P 
All figures (8)
Similar articles
Cited by
References
    1. Steiner TJ Stovner LJ andVos T.. GBD 2015: migraine is the third cause of disability in under 50s. J Headache Pain 2016; 17: 104. - PMC - PubMed
    1. Goadsby PJ, Holland PR, Martinsoliveira M, et al. Pathophysiology of migraine: a disorder of sensory processing. Physiol Rev 2017; 97: 553. - PMC - PubMed
    1. Mathew NT Kailasam J andSeifert T.. Clinical recognition of allodynia in migraine. Neurology 2004; 63: 848–852. - PubMed
    1. Noseda R and Burstein R.. Migraine pathophysiology: anatomy of the trigeminovascular pathway and associated neurological symptoms, CSD, sensitization and modulation of pain. Pain 2013; 154 Suppl 1 (6): S44-S53 - PubMed
    1. Moskowitz MA. Neurogenic inflammation in the pathophysiology and treatment of migraine. Neurology 1993; 43: 16–20. - PubMed
Show all 31 references
Publication types
MeSH terms
Substances
Full text links [x]
[x]
Cite
Copy Download .nbib
Format: AMA APA MLA NLM

NCBI Literature Resources

MeSH PMC Bookshelf Disclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.

Follow NCBI
Figure 5.
Figure 5.
Immunofluorescence of TLR4 and NF-κB p65 expression in the trigeminal pathway. The typical immunofluorescence samples were presented at the left part of the image, with the scale bar equalling to 50 μm. The right part showed the statistical results of NF-κB p65 expression in TG (a), TNC (b), and UCSC (c), respectively. All values given are the mean ± SD, n = 4. #P 

Figure 6.

The protein levels of IL-1β…

Figure 6.

The protein levels of IL-1β (a), TNF-α (b), and BDNF (c) in rat…

Figure 6.
The protein levels of IL-1β (a), TNF-α (b), and BDNF (c) in rat brain by enzyme-linked immunosorbent assay. All values given are the mean ± SD, n = 5. #P 

Figure 7.

Expression of microglia (a) and…

Figure 7.

Expression of microglia (a) and astrocytes (b) activating marker in rats’ medullary and…

Figure 7.
Expression of microglia (a) and astrocytes (b) activating marker in rats’ medullary and upper cervical spinal cord. Protein levels of Iba-1 (ionised calcium-binding adapter molecule 1) and GFAP (glia fibrillary acidic protein) were analysed by Western blot. Typical Western blot strips obtained were exhibited at the top of each image, and for all strips, each blot from left to right means sample from rat in group CON, IS, and TAK-242, respectively. All values given are the mean ± SD, n = 5. #P 

Figure 8.

Immunofluorescence of Iba-1 and GFAP…

Figure 8.

Immunofluorescence of Iba-1 and GFAP expression in the trigeminal pathway. The typical immunofluorescence…

Figure 8.
Immunofluorescence of Iba-1 and GFAP expression in the trigeminal pathway. The typical immunofluorescence samples were presented at the left part of the image, with the scale bar equalling to 50 μm. The right part showed the statistical results of Iba-1 expression in TNC (a) and UCSC (b), respectively. All values given are the mean ± SD, n = 4. #P 
All figures (8)
Similar articles
Cited by
References
    1. Steiner TJ Stovner LJ andVos T.. GBD 2015: migraine is the third cause of disability in under 50s. J Headache Pain 2016; 17: 104. - PMC - PubMed
    1. Goadsby PJ, Holland PR, Martinsoliveira M, et al. Pathophysiology of migraine: a disorder of sensory processing. Physiol Rev 2017; 97: 553. - PMC - PubMed
    1. Mathew NT Kailasam J andSeifert T.. Clinical recognition of allodynia in migraine. Neurology 2004; 63: 848–852. - PubMed
    1. Noseda R and Burstein R.. Migraine pathophysiology: anatomy of the trigeminovascular pathway and associated neurological symptoms, CSD, sensitization and modulation of pain. Pain 2013; 154 Suppl 1 (6): S44-S53 - PubMed
    1. Moskowitz MA. Neurogenic inflammation in the pathophysiology and treatment of migraine. Neurology 1993; 43: 16–20. - PubMed
Show all 31 references
Publication types
MeSH terms
Substances
Full text links [x]
[x]
Cite
Copy Download .nbib
Format: AMA APA MLA NLM

NCBI Literature Resources

MeSH PMC Bookshelf Disclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.

Follow NCBI
Figure 6.
Figure 6.
The protein levels of IL-1β (a), TNF-α (b), and BDNF (c) in rat brain by enzyme-linked immunosorbent assay. All values given are the mean ± SD, n = 5. #P 

Figure 7.

Expression of microglia (a) and…

Figure 7.

Expression of microglia (a) and astrocytes (b) activating marker in rats’ medullary and…

Figure 7.
Expression of microglia (a) and astrocytes (b) activating marker in rats’ medullary and upper cervical spinal cord. Protein levels of Iba-1 (ionised calcium-binding adapter molecule 1) and GFAP (glia fibrillary acidic protein) were analysed by Western blot. Typical Western blot strips obtained were exhibited at the top of each image, and for all strips, each blot from left to right means sample from rat in group CON, IS, and TAK-242, respectively. All values given are the mean ± SD, n = 5. #P 

Figure 8.

Immunofluorescence of Iba-1 and GFAP…

Figure 8.

Immunofluorescence of Iba-1 and GFAP expression in the trigeminal pathway. The typical immunofluorescence…

Figure 8.
Immunofluorescence of Iba-1 and GFAP expression in the trigeminal pathway. The typical immunofluorescence samples were presented at the left part of the image, with the scale bar equalling to 50 μm. The right part showed the statistical results of Iba-1 expression in TNC (a) and UCSC (b), respectively. All values given are the mean ± SD, n = 4. #P 
All figures (8)
Similar articles
Cited by
References
    1. Steiner TJ Stovner LJ andVos T.. GBD 2015: migraine is the third cause of disability in under 50s. J Headache Pain 2016; 17: 104. - PMC - PubMed
    1. Goadsby PJ, Holland PR, Martinsoliveira M, et al. Pathophysiology of migraine: a disorder of sensory processing. Physiol Rev 2017; 97: 553. - PMC - PubMed
    1. Mathew NT Kailasam J andSeifert T.. Clinical recognition of allodynia in migraine. Neurology 2004; 63: 848–852. - PubMed
    1. Noseda R and Burstein R.. Migraine pathophysiology: anatomy of the trigeminovascular pathway and associated neurological symptoms, CSD, sensitization and modulation of pain. Pain 2013; 154 Suppl 1 (6): S44-S53 - PubMed
    1. Moskowitz MA. Neurogenic inflammation in the pathophysiology and treatment of migraine. Neurology 1993; 43: 16–20. - PubMed
Show all 31 references
Publication types
MeSH terms
Substances
Full text links [x]
[x]
Cite
Copy Download .nbib
Format: AMA APA MLA NLM

NCBI Literature Resources

MeSH PMC Bookshelf Disclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.

Follow NCBI
Figure 7.
Figure 7.
Expression of microglia (a) and astrocytes (b) activating marker in rats’ medullary and upper cervical spinal cord. Protein levels of Iba-1 (ionised calcium-binding adapter molecule 1) and GFAP (glia fibrillary acidic protein) were analysed by Western blot. Typical Western blot strips obtained were exhibited at the top of each image, and for all strips, each blot from left to right means sample from rat in group CON, IS, and TAK-242, respectively. All values given are the mean ± SD, n = 5. #P 

Figure 8.

Immunofluorescence of Iba-1 and GFAP…

Figure 8.

Immunofluorescence of Iba-1 and GFAP expression in the trigeminal pathway. The typical immunofluorescence…

Figure 8.
Immunofluorescence of Iba-1 and GFAP expression in the trigeminal pathway. The typical immunofluorescence samples were presented at the left part of the image, with the scale bar equalling to 50 μm. The right part showed the statistical results of Iba-1 expression in TNC (a) and UCSC (b), respectively. All values given are the mean ± SD, n = 4. #P 
All figures (8)
Similar articles
Cited by
References
    1. Steiner TJ Stovner LJ andVos T.. GBD 2015: migraine is the third cause of disability in under 50s. J Headache Pain 2016; 17: 104. - PMC - PubMed
    1. Goadsby PJ, Holland PR, Martinsoliveira M, et al. Pathophysiology of migraine: a disorder of sensory processing. Physiol Rev 2017; 97: 553. - PMC - PubMed
    1. Mathew NT Kailasam J andSeifert T.. Clinical recognition of allodynia in migraine. Neurology 2004; 63: 848–852. - PubMed
    1. Noseda R and Burstein R.. Migraine pathophysiology: anatomy of the trigeminovascular pathway and associated neurological symptoms, CSD, sensitization and modulation of pain. Pain 2013; 154 Suppl 1 (6): S44-S53 - PubMed
    1. Moskowitz MA. Neurogenic inflammation in the pathophysiology and treatment of migraine. Neurology 1993; 43: 16–20. - PubMed
Show all 31 references
Publication types
MeSH terms
Substances
Full text links [x]
[x]
Cite
Copy Download .nbib
Format: AMA APA MLA NLM
Figure 8.
Figure 8.
Immunofluorescence of Iba-1 and GFAP expression in the trigeminal pathway. The typical immunofluorescence samples were presented at the left part of the image, with the scale bar equalling to 50 μm. The right part showed the statistical results of Iba-1 expression in TNC (a) and UCSC (b), respectively. All values given are the mean ± SD, n = 4. #P 
All figures (8)

References

    1. Steiner TJ Stovner LJ andVos T.. GBD 2015: migraine is the third cause of disability in under 50s. J Headache Pain 2016; 17: 104.
    1. Goadsby PJ, Holland PR, Martinsoliveira M, et al. Pathophysiology of migraine: a disorder of sensory processing. Physiol Rev 2017; 97: 553.
    1. Mathew NT Kailasam J andSeifert T.. Clinical recognition of allodynia in migraine. Neurology 2004; 63: 848–852.
    1. Noseda R and Burstein R.. Migraine pathophysiology: anatomy of the trigeminovascular pathway and associated neurological symptoms, CSD, sensitization and modulation of pain. Pain 2013; 154 Suppl 1 (6): S44-S53
    1. Moskowitz MA. Neurogenic inflammation in the pathophysiology and treatment of migraine. Neurology 1993; 43: 16–20.
    1. Malhotra R. Understanding migraine: Potential role of neurogenic inflammation. Ann Indian Acad Neurol 2016; 19: 175.
    1. Takeuchi O andAkira S.. Pattern recognition receptors and inflammation. Cell 2010; 140: 805.
    1. Gay NJ andGangloff M.. Structure and function of Toll receptors and their ligands. Annu Rev Biochem 2007; 76:141.
    1. Chen YL Law PY andLoh HH.. Nuclear factor kappaB signaling in opioid functions and receptor gene expression. J Neuroimmune Pharm 2006; 1: 270–279.
    1. Jack CS, Arbour N, Manusow J, et al. TLR signaling tailors innate immune responses in human microglia and astrocytes. J Immunol 2005; 175: 4320–4330.
    1. Chen ZY, Zhang XW, Yu L, et al. Spinal toll-like receptor 4-mediated signalling pathway contributes to visceral hypersensitivity induced by neonatal colonic irritation in rats. EJP 2015; 19: 176–186.
    1. Zhu H-T, Bian C, Yuan J-C, et al. Curcumin attenuates acute inflammatory injury by inhibiting the TLR4/MyD88/NF-κB signaling pathway in experimental traumatic brain injury. J Neuroinflammation. 2014; 11: 59-59.
    1. Agalave NM, Larsson M, Abdelmoaty S, et al. Spinal HMGB1 induces TLR4-mediated long-lasting hypersensitivity and glial activation and regulates pain-like behavior in experimental arthritis. Pain 2014; 155: 1802–1813.
    1. Lin J-J, Du Y, Cai W-K, et al. Toll-like receptor 4 signaling in neurons of trigeminal ganglion contributes to nociception induced by acute pulpitis in rats. Sci Rep 2015; 5: 12549.
    1. Eidson LN andMurphy AZ.. Blockade of Toll-like receptor 4 attenuates morphine tolerance and facilitates the pain relieving properties of morphine. J Neurosci 2013; 33: 15952–15963.
    1. Bettoni I, Comelli F, Rossini C, et al. Glial TLR4 receptor as new target to treat neuropathic pain: efficacy of a new receptor antagonist in a model of peripheral nerve injury in mice. Glia 2010; 56: 1312–1319.
    1. Zhao Y, Xin Y, Gao J, et al. Analgesic effect of TAK-242 on neuropathic pain in rats. Int J Clin Exp Med 2015; 8: 11202.
    1. Edelmayer RM, Vanderah TW, Majuta L, et al. Medullary pain facilitating neurons mediate allodynia in headache-related pain. Ann Neurol 2009; 65: 184–193.
    1. Su M, Ran Y, Han X, et al. Rizatriptan overuse promotes hyperalgesia induced by dural inflammatory stimulation in rats by modulation of the serotonin system. Eur J Neurosci 2016; 44: 2129–2138.
    1. Melocarrillo A andLopezavila A.. A chronic animal model of migraine, induced by repeated meningeal nociception, characterized by a behavioral and pharmacological approach. Cephalalgia Int J Headache 2013; 33: 1096.
    1. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983; 16: 109.
    1. Chaplan SR, Bach FW, Pogrel JW, et al. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 1994; 53: 55–63.
    1. Paxinos G andWatson C.. The rat brain in stereotaxic coordinates. Rat Brain Stereotaxic Coordinates 2007; 3: 6.
    1. Landy SH Rn MG andMa MD.. Clarification of developing and established clinical allodynia and pain-free outcomes. HeadacheJ Head Face Pain 2007; 47: 247–252.
    1. Louter MA, Bosker JE, van Oosterhout WP, et al. Cutaneous allodynia as a predictor of migraine chronification. Brain 2013; 136: 3489–3496.
    1. Woolf CJ. Central sensitization: implications for the diagnosis and treatment of pain. Pain 2011; 152: S2-S15.
    1. Aguggia M, Saracco MG, Cavallini M, et al. Sensitization and pain. Neurol Sci 2013; 34 Suppl 1: S37–S40.
    1. Akira S andTakeda K.. Toll-like receptor signalling. Nat Rev Immunol 2004; 4: 499.
    1. Woller SA, Ravula SB, Tucci FC, et al. Systemic TAK-242 prevents intrathecal LPS evoked hyperalgesia in male, but not female mice and prevents delayed allodynia following intraplantar formalin in both male and female mice: the role of TLR4 in the evolution of a persistent pain state. Brain Behav Immun 2016; 56: 271–280.
    1. Zhao Y, Xin Y, Gao J, et al. Analgesic effect of TAK-242 on neuropathic pain in rats. Int J Clin Exp Med 2015; 8: 11202–11207.
    1. Watkins LR, Hutchinson MR, Rice KC, et al. The “toll” of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting glia. Trends Pharmacol Sci 2009; 30: 581–591.

Source: PubMed

3
구독하다